Evidence map›Paper›PMID 36348995›Full record

ArticleRSC advances2022

In-depth drug delivery to tumoral soft tissues

Shumaila Sarwar, Sajid Bashir, Mulazim Hussain Asim, Fakhera Ikram, Arsalan Ahmed, Ume Omema, Anila Asif, Aqif Anwar Chaudhry, Yong Hu, Cem Bulent Ustundag

Open access · goldAbstract read
In one paragraph

Article in RSC advances, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.7field-weighted citation impact, top 36% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 11 citations in OpenAlex.

  1. Review
  2. Review
  3. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 4 institutions in 3 countries.

Shumaila SarwarInterdisciplinary Research Centre in Biomedical Materials, COMSATS University Islamabad Lahore Pakistan arsalanahmed@cuilahore.edu.pk.
Sajid BashirCollege of Pharmacy, University of Sargodha Sargodha Pakistan.
Mulazim Hussain AsimCollege of Pharmacy, University of Sargodha Sargodha Pakistan.
Fakhera IkramInterdisciplinary Research Centre in Biomedical Materials, COMSATS University Islamabad Lahore Pakistan arsalanahmed@cuilahore.edu.pk.
Arsalan AhmedInterdisciplinary Research Centre in Biomedical Materials, COMSATS University Islamabad Lahore Pakistan arsalanahmed@cuilahore.edu.pk.ORCID https://orcid.org/0000-0003-4099-0101
Ume OmemaInterdisciplinary Research Centre in Biomedical Materials, COMSATS University Islamabad Lahore Pakistan arsalanahmed@cuilahore.edu.pk.
Anila AsifInterdisciplinary Research Centre in Biomedical Materials, COMSATS University Islamabad Lahore Pakistan arsalanahmed@cuilahore.edu.pk.
Aqif Anwar ChaudhryInterdisciplinary Research Centre in Biomedical Materials, COMSATS University Islamabad Lahore Pakistan arsalanahmed@cuilahore.edu.pk.
Yong HuInstitute of Materials Engineering, National Laboratory of Solid State Microstructure, College of Engineering and Applied Sciences, Nanjing University Nanjing Jiangsu China.ORCID https://orcid.org/0000-0002-5394-6743
Cem Bulent UstundagDepartment of Bioengineering, Faculty of Chemical and Metallurgical Engineering, Yildiz Technical University Turkey.
COMSATS University Islamabad · PKUniversity of Sargodha · PKCollaborative Innovation Center of Advanced Microstructures · CNYıldız Technical University · TR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

A pH responsive nanoparticle-hydrogel hybrid drug delivery system was investigated for in-depth anticancer drug delivery to solid tumours. It consists of acid susceptible polymer nanoparticles loaded in a chitosan hydrogel. The hybrid formulation was characterized by UV-visible spectroscopy, FTIR, SEM, TEM, particle size analysis, zeta potential measurement and viscosity measurement. Drug encapsulation and nanoparticle loading efficiencies were found to be 48% and 72% respectively which describes the efficient interaction of the chemical entities in this hybrid drug delivery system. The hydrogel exhibited pH responsive behaviour: minimal drug and nanoparticle release at physiological pH but an increase in viscosity under acidic conditions and fast nanoparticle and drug release. The cytotoxicity of the drug loaded hydrogel was investigated against the MCF-7 breast cancer cell line along with the drug and nanoparticles without hydrogel. The drug loaded hydrogel showed a better cytotoxic effect on MCF-7 cancer cells. Thus, drug loaded nanoparticles containing hydrogel could be a better option for maximum drug distribution in tumours.

Identifiers

PMID36348995
PMCPMC9627957
OpenAlexW4308682721

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.